Literature DB >> 16221995

Negative symptoms and cognitive deficits: what is the nature of their relationship?

Philip D Harvey1, Danny Koren, Abraham Reichenberg, Christopher R Bowie.   

Abstract

Negative symptoms and cognitive deficits in schizophrenia share many features and are correlated in their severity on a cross-sectional basis. The question arises as to the nature of this relationship: are these symptoms the same, caused by the same factor (or factors); or is the nature of their relationship determined by other factors, such as definitional issues and common correlates? In this article we provide a conceptual overview for addressing this question and provide a selective review of the literature on the cross-sectional and longitudinal relationships between these two features of the illness. We describe 4 different models of the "true" relationship between these variables. Some data suggest that the relationship between these variables is determined by the definition of negative symptoms employed and that, in general, the correlation is moderate at the most. Further, path modeling suggests the possibility, to be addressed with later research, that correlations between negative and cognitive symptoms and everyday functional outcomes may influence the observed correlations between these variables. Thus, we conclude that negative and cognitive symptoms may be separable, if not conceptually independent, domains of the illness and that it might be possible to develop treatments that target negative symptoms and cognitive deficits independently.

Entities:  

Mesh:

Year:  2005        PMID: 16221995      PMCID: PMC2632205          DOI: 10.1093/schbul/sbj011

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  41 in total

1.  UCSD Performance-Based Skills Assessment: development of a new measure of everyday functioning for severely mentally ill adults.

Authors:  T L Patterson; S Goldman; C L McKibbin; T Hughs; D V Jeste
Journal:  Schizophr Bull       Date:  2001       Impact factor: 9.306

2.  Longitudinal study of symptoms and cognitive function in chronic schizophrenia.

Authors:  Catherine Hughes; Veena Kumari; William Soni; Mrigendra Das; Brendon Binneman; Sonia Drozd; Shaun O'Neil; Vallakalil Mathew; Tonmoy Sharma
Journal:  Schizophr Res       Date:  2003-02-01       Impact factor: 4.939

3.  Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort.

Authors:  Mary Cannon; Avshalom Caspi; Terrie E Moffitt; HonaLee Harrington; Alan Taylor; Robin M Murray; Richie Poulton
Journal:  Arch Gen Psychiatry       Date:  2002-05

4.  The convergence of neuropsychological testing and clinical ratings of cognitive impairment in patients with schizophrenia.

Authors:  P D Harvey; M R Serper; L White; M J Parrella; S R McGurk; P J Moriarty; C Bowie; N Vadhan; J Friedman; K L Davis
Journal:  Compr Psychiatry       Date:  2001 Jul-Aug       Impact factor: 3.735

5.  Cognitive correlates of the negative, disorganized, and psychotic symptom dimensions of schizophrenia.

Authors:  D S O'Leary; M Flaum; M L Kesler; L A Flashman; S Arndt; N C Andreasen
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2000       Impact factor: 2.198

6.  Relationship between premorbid functioning and symptom severity as assessed at first episode of psychosis.

Authors:  Jonathan Rabinowitz; Goedele De Smedt; Philip D Harvey; Michael Davidson
Journal:  Am J Psychiatry       Date:  2002-12       Impact factor: 18.112

7.  Premorbid functioning in a national population of male twins discordant for psychoses.

Authors:  A Reichenberg; J Rabinowitz; M Weiser; M Mark; Z Kaplan; M Davidson
Journal:  Am J Psychiatry       Date:  2000-09       Impact factor: 18.112

Review 8.  Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"?

Authors:  M F Green; R S Kern; D L Braff; J Mintz
Journal:  Schizophr Bull       Date:  2000       Impact factor: 9.306

9.  A comparison of clinical ratings with vocal acoustic measures of flat affect and alogia.

Authors:  Murray Alpert; Richard J Shaw; Enrique R Pouget; Kelvin O Lim
Journal:  J Psychiatr Res       Date:  2002 Sep-Oct       Impact factor: 4.791

10.  Correlates of change in functional status of institutionalized geriatric schizophrenic patients: focus on medical comorbidity.

Authors:  Joseph I Friedman; Philip D Harvey; Susan R McGurk; Leonard White; Michael Parrella; Tenko Raykov; Thomas Coleman; David N Adler; Kenneth L Davis
Journal:  Am J Psychiatry       Date:  2002-08       Impact factor: 18.112

View more
  123 in total

1.  [Early dementia as primary syndrome of schizophrenia].

Authors:  F U Lang; R Klug; M Kunath; C Palm; I Uttner; M Jäger
Journal:  Nervenarzt       Date:  2013-05       Impact factor: 1.214

2.  Predicting the severity of everyday functional disability in people with schizophrenia: cognitive deficits, functional capacity, symptoms, and health status.

Authors:  Philip D Harvey; Martin Strassnig
Journal:  World Psychiatry       Date:  2012-06       Impact factor: 49.548

3.  Clinical and Cognitive Insight in a Compensatory Cognitive Training Intervention.

Authors:  Cynthia Z Burton; Lea Vella; Elizabeth W Twamley
Journal:  Am J Psychiatr Rehabil       Date:  2011-10-01

Review 4.  A review of negative symptom assessment strategies in youth at clinical high-risk for psychosis.

Authors:  Gregory P Strauss; Andrea Pelletier-Baldelli; Katherine Frost Visser; Elaine F Walker; Vijay A Mittal
Journal:  Schizophr Res       Date:  2020-06-07       Impact factor: 4.939

Review 5.  Persistent negative symptoms in schizophrenia: an overview.

Authors:  Robert W Buchanan
Journal:  Schizophr Bull       Date:  2006-11-10       Impact factor: 9.306

6.  The NIMH-MATRICS consensus statement on negative symptoms.

Authors:  Brian Kirkpatrick; Wayne S Fenton; William T Carpenter; Stephen R Marder
Journal:  Schizophr Bull       Date:  2006-02-15       Impact factor: 9.306

7.  Premorbid IQ varies across different definitions of schizophrenia.

Authors:  Annick Urfer Parnas; Lennart Jansson; Peter Handest; Jan Nielsen; Ditte Sæbye; Josef Parnas
Journal:  World Psychiatry       Date:  2007-02       Impact factor: 49.548

8.  Clarifying the overlap between motivation and negative symptom measures in schizophrenia research: A meta-analysis.

Authors:  Lauren Luther; Melanie W Fischer; Ruth L Firmin; Michelle P Salyers
Journal:  Schizophr Res       Date:  2018-12-19       Impact factor: 4.939

Review 9.  Progress in defining optimal treatment outcome in schizophrenia.

Authors:  Gary Remington; George Foussias; Ofer Agid
Journal:  CNS Drugs       Date:  2010-01       Impact factor: 5.749

10.  Negative symptoms and functioning during the first year after a recent onset of schizophrenia and 8 years later.

Authors:  Joseph Ventura; Kenneth L Subotnik; Michael J Gitlin; Denise Gretchen-Doorly; Arielle Ered; Kathleen F Villa; Gerhard S Hellemann; Keith H Nuechterlein
Journal:  Schizophr Res       Date:  2014-12-08       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.